The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult). These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes. An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease. This report aims to provide a comprehensive presentation of the global market for Microbiome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome Therapeutics. This report contains market size and forecasts of Microbiome Therapeutics in global, including the following market information: Global Microbiome Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions) Global top five companies in 2022 (%) The global Microbiome Therapeutics market was valued at US$ 94 million in 2022 and is projected to reach US$ 825.1 million by 2029, at a CAGR of 36.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI is about 52%. For Microbiome Therapeutics Pipeline Product, SER-109, ABI-H0731, ribaxamase, SYN-010 have the most investment in research, there are in Phase 3, PHASE 1b and Phase 2. North American is the largest market, It occupy nearly 37% market share. Following North American, Europe is the second largest market with the consumption market share of 30%. Market competition is not intense. Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon and PureTech are the leading Developers in the industry, with about 60% market shares. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Microbiome Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Microbiome Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions) Global Microbiome Therapeutics Market Segment Percentages, by Type, 2022 (%) Upper GIT Lower GIT Global Microbiome Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions) Global Microbiome Therapeutics Market Segment Percentages, by Application, 2022 (%) C. difficile Infection (CDI) Inflammatory Bowel Disease (IBD) Orphan Drug Immuno-oncology Others Global Microbiome Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) Global Microbiome Therapeutics Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Microbiome Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions) Key companies Microbiome Therapeutics revenues share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: Seres Therapeutics Assembly Biosciences Synthetic Biologics Interxon PureTech Synlogic Enterome BioScience 4D Pharma Second Genome AOBiome C3 Jian Rebiotix MicroBiome Therapeutics LLC Metabiomics Ritter Pharmaceuticals Symberix OpenBiome Azitra Symbiotix Biotherapies Osel Metabogen Outline of Major Chapters: Chapter 1: Introduces the definition of Microbiome Therapeutics, market overview. Chapter 2: Global Microbiome Therapeutics market size in revenue. Chapter 3: Detailed analysis of Microbiome Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Microbiome Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports 1.1 Microbiome Therapeutics Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Microbiome Therapeutics Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process
